Søgning på udtrykket 'meningitis' giver 52 resultater


Dokumenter [5] Sider [1] Kalender [6] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]

Dokumenter [5]

Udgiver: Dansk Selskab for Infektionsmedicin Arbejdsgruppe: Anne-Mette Lebech, Birgitte Rønde Hansen, Christian Brandt, Hans Rudolf von Lüttichau, Jacob Bodilsen, Lothar Wiese, Lykke Larsen, Trine Mogensen.

Udgiver: Dansk Selskab for Infektionsmedicin 2018 Arbejdsgruppe: Anne-Mette Lebech, Birgitte Rønde Hansen, Christian Brandt, Hans Rudolph von Lüttichau, Jacob Bodilsen, Jannik Helweg-Larsen, Lothar Wiese, Lykke Larsen, Trine Mogensen.

Rapport og anbefaling vedrørende ulemper og fordele ved henholdsvis at undlade eller gennemføre lumbalpunktur for patienter i blodfortyndende behandling mistænkt for akut bakteriel meningitis.

Denne vejledning er tiltænkt diagnostik og behandling af formodet Lyme neuroborreliose hos voksne. Vejledningen er udarbejdet som et supplement til Borrelia klaringsrapport (2014).

Af Rikke Krogh-Madsen, formand for Dansk Selskab for Infektionsmedicin. Der er lige nu massivt fokus på læger der har begået fejl. Aktuelt drejer det sig om behandling af meningokoksygdom. Bestyrelsen for Dansk Selskab for Infektionsmedicin (DSI) kender ikke til detaljerne i de konkrete sager og har ikke set sagsakterne. Dette er derfor en generel udtalelse som tager udgangspunkt i udmeldingen fra Patienterstatningen vedr. de tre meningokok-sager.

Sider [1]

…epatitis: Nina Weis, Peer B Christensen, Alex Lund Laursen Hepatitis A, Hepatitis B og C guidelines, Malaria: Carsten Schade Larsen, Lasse Skafte Vestergaard, Peter Ellekvist, Signe Maj Sørensen og Kim David Malaria, Meningitis og encephalitis: Anne Mette Lebech, Christian Brandt, Lykke Larsen, Jacob Bodilsen, Lothar Wiese, Birgitte Rønde Hansen, Hans Rudolf von Lüttchau Akut bakteriel meningitis, Viral meningitis, Encephalitis, Lumbalpunktur af patienter …


Kalender [6]

1. juni, Rigshospitalet
4. maj 2018, Hindsgavl, Middelfart
28. marts 2017, Hvidovre Universitetshospital
17. juni 2015, CHIP, Øster Allé 56, 2100 København Ø
6. marts 2015, Auditorium A, Teilumbygningen, Rigshospitalet

Nyt fra tidsskrifterne [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
BMC Infectious Diseases
8.08.2022
. Abstract. . Background. The most appropriate alternative to induction therapy for HIV-associated cryptococcal meningitis (CM) remains unclear when standard treatment is unavailable, inaccessible, intolerable, or ineffective. . . Methods. A prospective, multi-centre cohort study was conducted to analyze the data of 156 HIV-infected p…
BMC Infectious Diseases
8.08.2022
. Abstract. . Background. The most appropriate alternative to induction therapy for HIV-associated cryptococcal meningitis (CM) remains unclear when standard treatment is unavailable, inaccessible, intolerable, or ineffective. . . Methods. A prospective, multi-centre cohort study was conducted to analyze the data of 156 HIV-infected p…
International Journal of Infectious Diseases
4.08.2022
: Providing country-specific estimates of case-fatality and sequelae from bacterial meningitis (BM) is important to evaluate and monitor progress towards the World Health Organisation's roadmap to “Defeating meningitis by 2030”.
New England Journal of Medicine
27.07.2022
New England Journal of Medicine, Volume 387, Issue 4, Page 380-381, July 2022.
Clinical Infectious Diseases
21.07.2022
AbstractBackgroundIt is unknown whether persons with symptomatic cryptococcal meningitis detected during routine blood cryptococcal antigen (CrAg) screening have better survival than persons presenting with overt meningitis.MethodsWe prospectively enrolled HIV-infected Ugandans with cryptococcal meningitis from December 2018 to December 2021. Participants were treated with amphotericin-based combination therapy. We compared outcomes between persons who were CrAg screened then referred to hospital versus tho…
BMC Infectious Diseases
18.07.2022
. Abstract. . Background. Meningitis is considered a life-threatening infection with high mortality all over the world. Hemophilus influenzae (H. influenzae) and Streptococcus pneumoniae (S. pneumoniae) are regarded as the two most common infectious agents causing bacterial meningitis. This study aimed to identify H. influenzae and S. pneumoniae serotypes in blood and cerebrospinal fluid (CSF) of pediatric patients with …
BMC Infectious Diseases
18.07.2022
. Abstract. . Background. Meningitis is considered a life-threatening infection with high mortality all over the world. Hemophilus influenzae (H. influenzae) and Streptococcus pneumoniae (S. pneumoniae) are regarded as the two most common infectious agents causing bacterial meningitis. This study aimed to identify H. influenzae and S. pneumoniae serotypes in blood and cerebrospinal fluid (CSF) of pediatric patients with …
BMJ Open
14.07.2022
. Objectives. To assess practice in the care of adults with suspected community-acquired bacterial meningitis in the UK and Ireland. . Design. Retrospective cohort study. . Setting. 64 UK and Irish hospitals. . Participants. 1471 adults with community-acquired meningitis of any aetiology in 2017. . Results. None of the audit standards, from the 2016 UK Joint Specialists Societies guideline on diagnosis and management of meningitis, were met in all cases. With respect to 20 of 30 assessed stand…
International Journal of Infectious Diseases
14.07.2022
: Cytomegalovirus (CMV) viremia is associated with increased mortality in persons with HIV. We previously demonstrated that CMV viremia was a risk factor for 10-week mortality in antiretroviral therapy (ART)-naïve persons with cryptococcal meningitis. We investigated whether similar observations existed over a broader cohort of HIV-associated meningitis at 18 weeks.
International Journal of Infectious Diseases
7.07.2022
LETTER
International Journal of Infectious Diseases
24.06.2022
To study the clinical features of bacterial meningitis in myeloma patients.
International Journal of Infectious Diseases
24.06.2022
Fungal meningitis is typically diagnosed by culture, sometimes by molecular diagnosis or histology. However, cultures lack sensitivity and require several days to grow. A sensitive biomarker that could rapidly identify a fungal central nervous system (CNS) infection could be one step among several towards improving diagnosis and treatment.
Lancet Infectious Diseases
22.06.2022
Cryptococcal meningitis, a major cause of meningitis in adults living with HIV infection, accounts for 15% of global HIV-associated mortality.1 Treatment of cryptococcal meningitis involves three phases: induction, consolidation, and maintenance. The induction phase, which aims at reducing cerebral and meningeal fungal burden crucial for early survival, requires combination antifungal therapy and management of increased cerebrospinal fluid intracranial pressure. WHO in 2018 recommended at induction either 1…
Lancet Infectious Diseases
22.06.2022
In-hospital mortality among patients treated with a flucytosine-containing regimen was comparable to reduced mortality reported in patients receiving a flucytosine-containing regimen in a recent multicentre African clinical trial. Flucytosine-based treatment can be delivered in routine care in a middle-income country with a substantial survival benefit.
Infection
22.06.2022
…Nervous System (iCNS), rapid identification of causing pathogens is crucial for survival and to avoid long-term sequelae. Targeted therapy may reduce side effects and development of antibiotic resistance. New molecular-based syndromic tests such as the “meningitis/encephalitis panel” (MEP) allow accelerated pathogen identification from cerebrospinal fluid. We conducted a clinical study to evaluate the MEP’s efficacy in paediatric patients. . . …
Infection
22.06.2022
…Nervous System (iCNS), rapid identification of causing pathogens is crucial for survival and to avoid long-term sequelae. Targeted therapy may reduce side effects and development of antibiotic resistance. New molecular-based syndromic tests such as the “meningitis/encephalitis panel” (MEP) allow accelerated pathogen identification from cerebrospinal fluid. We conducted a clinical study to evaluate the MEP’s efficacy in paediatric patients. . . …
Infection
3.06.2022
. Abstract. . Purpose. To investigate the prevalence of neuro-functional disability and its determinants 12 months after community-acquired bacterial meningitis (CABM) in adult patients. . . Methods. In a prospective multicenter cohort study (COMBAT), all consecutive cases of CABM were enrolled and followed up for 12 months. Neuro-functional disabi…
Infection
3.06.2022
. Abstract. . Purpose. To investigate the prevalence of neuro-functional disability and its determinants 12 months after community-acquired bacterial meningitis (CABM) in adult patients. . . Methods. In a prospective multicenter cohort study (COMBAT), all consecutive cases of CABM were enrolled and followed up for 12 months. Neuro-functional disabi…
PLoS One Infectious Diseases
11.05.2022
by Aquino Albino Nhantumbo, Charlotte Elizabeth Comé, Plácida Iliany Maholela, Alcides Moniz Munguambe, Paulino da Costa, Mariana Mott, Gabriella Rosa Cunha, Lúcia Chambal, Cícero Dias, Vlademir Vicente Cantarelli, Eduardo Samo Gudo. Background Meningitis remains an important cause of morbi-mortality in adults in sub-Saharan Africa. Data on the etiological investigation of meningitis in adults in Mozambique is limited and most studies were conducted in southern Mozambique. Identification of the etiolog…
Clinical Microbiology and Infection
11.05.2022
Escherichia coli meningitis is frequent and has been widely described among newborns (1). The strains involved show an oligoclonal distribution within only a few sequence type complexes (STcs) and often harbor the K1 capsular antigen. Among adults, E. coli accounts for 0.5-3% of meningitis and has poor outcome, but data are scarce and genomic characteristics of responsible strains are often lacking (2). We conducted a multicentric retrospective study, including all cases referred for expertise to our nation…

Aktuelle smitsomme sygdomme [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
ProMED
13.08.2022
Meningitis - Neisseria -- Australia
ProMED
6.08.2022
Meningitis - Neisseria -- Australia
Medscape Infectious Diseases
6.07.2022
"The giant African land snail.is one of the most invasive pests on the planet, causing agricultural and environmental damage wherever it is found." .
ProMED
24.06.2022
Meningitis - Neisseria -- United States
ProMED
20.06.2022
Meningitis -- Italy
ProMED
12.06.2022
Meningitis - Neisseria -- Nigeria
ProMED
31.05.2022
Meningitis - Neisseria -- Australia
ProMED
28.05.2022
Meningitis - Neisseria -- Australia
ProMED
13.05.2022
Meningitis -- South Sudan
Statens Serum Institut
11.05.2022
I 2021 blev der anmeldt 86 tilfælde af bakteriel meningitis. Det er lidt flere end året før. Til gengæld var der færre, der døde af sygdommen, end i både 2019 og 2020. Det viser den årlige opgørelse fra Statens Serum Institut.
ProMED
7.05.2022
Meningitis - Neisseria -- United States
Medscape Infectious Diseases
25.04.2022
Early diagnosis is crucial for providing the appropriate treatment for meningitis. High-sensitivity and specificity molecular techniques can help distinguish between bacterial and viral etiologies. .
ProMED
24.04.2022
Meningitis - Neisseria -- Australia
ProMED
23.04.2022
Meningitis - Neisseria -- Australia
ProMED
18.04.2022
Meningitis - Neisseria -- United States
Medscape Infectious Diseases
8.10.2021
WHO has outlined an ambitious plan to reduce cases of meningitis by 50% and deaths by 70% by 2030.
ProMED
21.09.2021
Meningitis - Neisseria -- DR CongoThe national health authorities, in coordination with WHO, are providing support in responding to this event. The response measures include the following:- The local committee for the management of health emergencies is conducting regular meetings to coordinate response activities at the provincial level as well as in the Banalia health zone;- a reactive vaccination campaign against meningitis, with vaccine containing meningococcal W antigen, is being planned;- continuation…

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2022 Dansk Selskab for Infektionsmedicin

CVR: 33634307

version: 2.11.0 ● design: Christian Philip Fischer

Side indlæst på 0,478 s

Cookies og privatliv